Evidence map›Paper›PMID 30239619›Full record

ArticleCarcinogenesis2018

Lack of APC somatic mutation is associated with early-onset colorectal cancer in African Americans.

Rosa M Xicola, Zarko Manojlovic, Gaius J Augustus, Sonia S Kupfer, Rajyasree Emmadi, Victoria Alagiozian-Angelova, Tim Triche, Bodour Salhia, John Carpten, Xavier Llor and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Carcinogenesis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Molecular genetics of early-onset colorectal cancer.World journal of biological chemistry · 2023
    Review
  11. Review
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 1 country.

Rosa M XicolaDepartment of Internal Medicine and Yale Cancer Center, Yale University, New Haven, CT, USA.
Zarko ManojlovicTranslational Genomics Research Institute, Division of Integrated Cancer Genomics, Phoenix, AZ, USA.
Gaius J AugustusCancer Biology Graduate Interdisciplinary Program, University of Arizona, Tucson, AZ, USA.
Sonia S KupferUniversity of Chicago Medicine, Section of Gastroenterology, Hepatology and Nutrition, Chicago, IL, USA.
Rajyasree EmmadiDepartment of Pathology, University of Illinois at Chicago, Chicago, IL, USA.
Victoria Alagiozian-AngelovaDepartment of Pathology, Cook County Health and Hospitals System, Chicago, IL, USA.
Tim TricheDepartment of Translational Genomics, Keck School of Medicine of University of Southern California, Los Angeles, CA, USA.
Bodour SalhiaDepartment of Translational Genomics, Keck School of Medicine of University of Southern California, Los Angeles, CA, USA.
John CarptenTranslational Genomics Research Institute, Division of Integrated Cancer Genomics, Phoenix, AZ, USA.
Xavier LlorDepartment of Internal Medicine and Yale Cancer Center, Yale University, New Haven, CT, USA.
Nathan A EllisDepartment of Cellular and Molecular Medicine and University of Arizona Cancer Center, University of Arizona., Tucson, AZ, USA.
University of Southern California · USUniversity of Arizona · USYale Cancer Center · USCook County Health and Hospitals System · USUniversity of Chicago · USUniversity of Illinois Chicago · USVan Andel Institute · US

Funding

VITAMIN AP30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Teri L Bankhead · 1985 to 2026
$110.2M
Integrative Cancer Scholars Training GrantT32CA009213 · NCI · UNIVERSITY OF ARIZONA · PI CAREW, JENNIFER S, CURIEL-LEWANDROWSKI, CLARA · 1985 to 2024
$8.6M
TRAINING PROGRAM IN INVESTIGATIVE GASTROENTEROLOGYT32DK007017 · NIDDK · YALE UNIVERSITY · PI Fred Sanford Gorelick, Liza Konnikova · 1986 to 2026
$7.1M
Epigenetic dysregulation in APC-negative colorectal cancerR01CA242914 · NCI · UNIVERSITY OF ARIZONA · PI ELLIS, NATHAN A., LLOR, XAVIER · 2020 to 2024
$2.4M
Genetic risk factors in African American colorectal cancer patientsU01CA153060 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ELLIS, NATHAN A. · 2010 to 2014
$1.7M
NCI NIH HHS P30 CA023074NCI NIH HHS R01 CA242914NCI NIH HHS T32 CA009213NCI NIH HHS U01 CA153060NIDDK NIH HHS T32 DK007017
6 · The paper itself

Abstract

African Americans (AAs) have higher incidence and mortality rates of colorectal cancer (CRC) compared with other US populations. They present with more right-sided, microsatellite stable disease and are diagnosed at earlier ages compared with non-Hispanic Whites (NHWs). To gain insight into these trends, we conducted exome sequencing (n = 45), copy number (n = 33) and methylation analysis (n = 11) of microsatellite stable AA CRCs. Results were compared with data from The Cancer Genome Atlas (TCGA). Two of the 45 tumors contained POLE mutations. In the remaining 43 tumors, only 27 (63%) contained loss-of-function mutations in APC compared with 80% of TCGA NHW CRCs. APC-mutation-negative CRCs were associated with an earlier onset of CRC (P = 0.01). They were also associated with lower overall mutation burden, fewer copy number variants and a DNA methylation signature that was distinct from the CpG island methylator phenotype characterized in microsatellite unstable disease. Three of the APC-mutation-negative CRCs had loss-of-function mutations in BCL9L. Mutations in driver genes identified by TCGA exome analysis were less frequent in AA CRC cases than TCGA NHWs. Genes that regulate the WNT signaling pathway, including SOX9, GATA6, TET1, GLIS1 and FAT1, were differentially hypermethylated in APC-mutation-negative CRCs, suggesting a novel mechanism for cancer development in these tumors. In summary, we have identified a subtype of CRC that is associated with younger age of diagnosis, lack of APC mutation, microsatellite and chromosome stability, lower mutation burden and distinctive methylation changes.

Indexed as

Adenomatous Polyposis Coli ProteinBlack or African AmericanCadherinsColorectal NeoplasmsDNA-Binding ProteinsDNA Copy Number VariationsDNA MethylationExome SequencingFemaleGATA6 Transcription FactorHumansMaleMicrosatellite InstabilityMicrosatellite RepeatsMiddle AgedMixed Function OxygenasesAdenomatous Polyposis Coli ProteinAPC protein, humanBCL9L protein, humanCadherinsDNA-Binding ProteinsFAT1 protein, humanGATA6 protein, humanGATA6 Transcription FactorGLIS1 protein, humanMixed Function OxygenasesProto-Oncogene ProteinsSOX9 protein, humanSOX9 Transcription FactorTET1 protein, humanTranscription Factors

Identifiers

PMID30239619
PMCPMC6292413
OpenAlexW2892322640

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.